Sintilimab
Drug timelines are a Plus or Pro feature.
315 regulatory and trial events tracked for Sintilimab, covering 2018-12-06 to 2026-07-21. Get the full timeline:
Most recent: Clinical Trial Results: Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study [Phase 2]